The 5-aminolevulinic acid-induced porphyrin biosynthesis in benign and malignant cells of the skin.
In fluorescence diagnosis and photodynamic therapy of neoplastic tissues 5-aminolevulinic acid is used to synthesize endogenous porphyrins as photosensitizers. The efficacy of neoplastic tissues to fluorescence diagnosis and photodynamic therapy is thought to be dependent on the total level of intralesional formed porphyrins. The available profiles of porphyrin metabolites in normal and in neoplastic cell lines after administration of 5-aminolevulinic acid vary considerably. Thus, this is the first in-vitro study which compares the porphyrin biosynthesis in normal skin cells (HaCaT, fibroblasts) with melanoma cells (Bro, SKMel-23, SKMel-28). After incubation with 1 mM 5-aminolevulinic acid, kinetics of porphyrin levels and metabolites were determined in the cells and the corresponding supernatants. Exogenous 5-aminolevulinic acid induced porphyrin formation in all cells with maximum values after an incubation period of 16-36 h. Increase of porphyrin levels varied from 10- to 80-fold (SKMel-28>HaCaT>fibroblasts>SKMel-23>>Bro) with minimum 1.5 times higher levels of porphyrins in the supernatants than in the cells. In cells and supernatants protoporphyrin and coproporphyrin were the predominantly formed porphyrin metabolites. Metastatic melanoma cells (SKMel-23, SKMel-28) accumulated much higher porphyrin levels than primary melanoma cells (Bro). In conclusion, by optimizing the treatment modalities, especially the light source, topical photodynamic therapy (PDT) could become a treatment alternative of melanoma metastases in progressive disease.
Lang
K
K
Department of Dermatology, Heinrich-Heine-University, Moorenstrasse 5, 40225 Duesseldorf, Germany. kerstin.lang@med.uni-duesseldorf.de
Bolsen
K
K
Stahl
W
W
Ruzicka
T
T
Sies
H
H
Lehmann
P
P
Fritsch
C
C
D000622:Aminolevulinic Acid / Q000378:metabolism*; D002461:Cell Line, Transformed; D006801:Humans; D017319:Photosensitizing Agents / Q000378:metabolism*; D011166:Porphyrins / Q000096:biosynthesis*; D012878:Skin Neoplasms; D014407:Tumor Cells, Cultured
D017319:Photosensitizing Agents; D011166:Porphyrins; D000622:Aminolevulinic Acid